{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:25:42Z","timestamp":1790749542872,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.dld.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T02:08:45Z","timestamp":1555553325000},"page":"1400-1408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activation"],"prefix":"10.1016","volume":"51","author":[{"given":"Wanda","family":"Delogu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Caligiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bugianesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Coratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Macias-Barragan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Galastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Maira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8629-0878","authenticated-orcid":false,"given":"Fabio","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2019.03.002_bib0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/iub.1392","article-title":"Myostatin: expanding horizons","volume":"67","author":"Sharma","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.dld.2019.03.002_bib0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.dld.2019.03.002_bib0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.dld.2019.03.002_bib0020","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.cellsig.2011.05.003","article-title":"Myostatin: a novel insight into its role in metabolism, signal pathways, and expression regulation","volume":"23","author":"Huang","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.dld.2019.03.002_bib0025","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2337\/db08-0245","article-title":"Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance","volume":"58","author":"Wilkes","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.dld.2019.03.002_bib0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI0213562","article-title":"Suppression of body fat accumulation in myostatin-deficient mice","volume":"109","author":"McPherron","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dld.2019.03.002_bib0035","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1210\/jc.2003-032047","article-title":"Changes in muscle myostatin expression in obese subjects after weight loss","volume":"89","author":"Milan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.dld.2019.03.002_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006575","article-title":"Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways","volume":"4","author":"Palsgaard","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2019.03.002_bib0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.nutr.012809.104726","article-title":"The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome","volume":"30","author":"Jornayvaz","year":"2010","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.dld.2019.03.002_bib0050","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.2174\/1381612819666131206111352","article-title":"The metabolic syndrome and chronic liver disease","volume":"20","author":"Rosselli","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.dld.2019.03.002_bib0055","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.cgh.2015.07.029","article-title":"Nonalcoholic fatty liver disease review: diagnosis, treatment, and outcomes","volume":"13","author":"Ahmed","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.03.002_bib0060","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.002_bib0065","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.002_bib0070","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","article-title":"Hepatic fibrosis: concept to treatment","volume":"62","author":"Trautwein","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.002_bib0075","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.dld.2019.03.002_bib0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0035-1550060","article-title":"Emerging and disease-specific mechanisms of hepatic stellate cell activation","volume":"35","author":"Wallace","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2019.03.002_bib0085","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2015.10.016","article-title":"MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease","volume":"64","author":"Petta","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.002_bib0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11010-008-9813-6","article-title":"Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs: resistance to chemical induced apoptosis","volume":"316","author":"Di Maira","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.dld.2019.03.002_bib0095","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1136\/gutjnl-2014-306761","article-title":"The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma","volume":"64","author":"Rovida","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.03.002_bib0100","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/hep.21995","article-title":"Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells","volume":"47","author":"Caligiuri","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.002_bib0105","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.27141","article-title":"Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice","volume":"60","author":"Locatelli","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.002_bib0110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/gutjnl-2016-313114","article-title":"CHK2 overexpression and mislocalisation within mitotic structures enhances chromosomal instability and hepatocellular carcinoma progression","volume":"67","author":"Carloni","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.03.002_bib0115","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0016-5085(97)70144-6","article-title":"Phosphatidylinositol 3-kinase is required for platelet-derived growth factor\u2019s actions on hepatic stellate cells","volume":"112","author":"Marra","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.002_bib0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/labinvest.2009.112","article-title":"Curcumin limits the fibrogenic evolution of experimental steatohepatitis","volume":"90","author":"Vizzutti","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.dld.2019.03.002_bib0125","series-title":"Signaling pathways in liver diseases","first-page":"34","article-title":"Stellate cells","author":"Caligiuri","year":"2015"},{"key":"10.1016\/j.dld.2019.03.002_bib0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2012.06.004","article-title":"A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches","volume":"143","author":"Seki","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.002_bib0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.dld.2019.03.002_bib0140","first-page":"17","article-title":"Molecular pathogenesis of NASH","author":"Caligiuri","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2019.03.002_bib0145","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep.23046","article-title":"Adipokines in liver diseases","volume":"50","author":"Marra","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.002_bib0150","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/hep.26695","article-title":"Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice","volume":"59","author":"De Minicis","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.002_bib0155","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/apt.13889","article-title":"Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"45","author":"Petta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.03.002_bib0160","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jhep.2016.07.040","article-title":"Sarcopenia from mechanism to diagnosis and treatment in liver disease","volume":"65","author":"Dasarathy","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.002_bib0165","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurjhf\/hfr024","article-title":"Increased plasma myostatin in heart failure","volume":"13","author":"Gruson","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.dld.2019.03.002_bib0170","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/path.3005","article-title":"The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells","volume":"226","author":"Novo","year":"2012","journal-title":"J Pathol"},{"key":"10.1016\/j.dld.2019.03.002_bib0175","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.4049\/jimmunol.1400861","article-title":"IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-beta receptor on hepatic stellate cells in a JNK-dependent manner","volume":"193","author":"Fabre","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.dld.2019.03.002_bib0180","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.cellsig.2007.07.002","article-title":"Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells","volume":"19","author":"Huang","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.dld.2019.03.002_bib0185","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00441-015-2139-2","article-title":"Myostatin induces interstitial fibrosis in the heart via TAK1 and p38","volume":"361","author":"Biesemann","year":"2015","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.dld.2019.03.002_bib0190","doi-asserted-by":"crossref","first-page":"19371","DOI":"10.1074\/jbc.M802585200","article-title":"Myostatin directly regulates skeletal muscle fibrosis","volume":"283","author":"Li","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dld.2019.03.002_bib0195","first-page":"3957","article-title":"Inhibition of myostatin reverses muscle fibrosis through apoptosis","volume":"125","author":"Bo Li","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.dld.2019.03.002_bib0200","doi-asserted-by":"crossref","first-page":"25852","DOI":"10.1074\/jbc.M704146200","article-title":"Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis","volume":"282","author":"Zhu","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dld.2019.03.002_bib0205","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.1743-6109.2008.00847.x","article-title":"Profibrotic role of myostatin in Peyronie\u2019s disease","volume":"5","author":"Cantini","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.dld.2019.03.002_bib0210","doi-asserted-by":"crossref","first-page":"C1213","DOI":"10.1152\/ajpcell.00179.2011","article-title":"Myostatin-null mice exhibit delayed skin wound healing through the blockade of transforming growth factor-beta signaling by decorin","volume":"302","author":"Zhang","year":"2012","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819301136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819301136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:10:12Z","timestamp":1761624612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865819301136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1590865819301136"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2019.03.002","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activation","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}